Ammonul (Ucyclyd Pharma Inc.)


Welcome to the PulseAid listing for the Ammonul drug offered from Ucyclyd Pharma Inc.. This Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ucyclyd Pharma Inc.
NON-PROPRIETARY NAME: sodium phenylacetate and sodium benzoate
SUBSTANCE NAME: SODIUM PHENYLACETATE; SODIUM BENZOATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-02-17
END MARKETING DATE: 0000-00-00


Ammonul HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAmmonul from Ucyclyd Pharma Inc.
LABELER NAME: Ucyclyd Pharma Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100; 100(mg/mL; mg/mL)
START MARKETING DATE: 2005-02-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62592-720_d4391516-4c73-4290-90c6-f1fb14e62277
PRODUCT NDC: 62592-720
APPLICATION NUMBER: NDA020645

Other SODIUM PHENYLACETATE; SODIUM BENZOATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
MAIA PHARMACEUTICALS, INCSODIUM PHENYLACETATE AND SODIUM BENZOATE
Mylan Institutional LLCSodium Phenylacetate and Sodium Benzoate
Oceanside PharmaceuticalsSodium Phenylacetate and Sodium Benzoate
Trigen Laboratories, LLCSODIUM PHENYLACETATE and SODIUM BENZOATE
Ucyclyd Pharma Inc.Ammonul
Valeant Pharmaceuticals North America LLCAmmonul
Zydus Pharmaceuticals USA Inc.SODIUM PHENYLACETATE AND SODIUM BENZOATE